Analyst Ratings for Cardiome Pharma (CRME)

CRME Rating Summary

CRME Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRME
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $9.50 (+94.7%) * Over Last 12-Mos
Rating Score: 5.5 / 10   Percentile Rank: 60%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/1/2016 H.C. Wainwright New Coverage Buy
(N/A)
9.50
(N/A)
4.68 4.88 4.27% Details
1/8/2015 Brean Capital New Coverage Buy
(N/A)
13.00
(N/A)
9.30 4.88 -47.53% Details
Like CRME Ratings? Also take a look at STDY, OCLS, ONTX, ONTY

CRME Ratings News